DISEASE SCANNER
Global Incurable Diseases Tracker
Multiple Endocrine Neoplasia (MEN)
A group of inherited syndromes causing tumors in multiple endocrine glands. MEN1 (menin gene): parathyroid, pituitary, pancreas. MEN2 (RET gene): medullary thyroid carcinoma, pheochromocytoma, parathyroid hyperplasia.
50.0K
15
Symptoms
Treatment Options
Risk Factors
Diagnostic Methods
- 1Genetic testing
- 2Clinical evaluation
- 3Family history assessment
- 4Specialized laboratory tests
- 5Imaging studies
- 6Biopsy (if applicable)
Prognosis
MEN1: Median survival reduced by 10-15 years without screening; parathyroid and pancreatic tumors are main causes of morbidity. Regular screening allows early intervention. MEN2A: Prophylactic thyroidectomy by age 5 virtually eliminates medullary thyroid cancer mortality. MEN2B: Earlier thyroidectomy (by 6 months) needed due to aggressive MTC. Pheochromocytoma is rarely malignant but requires monitoring. Genetic testing of at-risk family members essential.
Prevention
- Genetic counseling
- Carrier screening
- Prenatal diagnosis
- Preimplantation genetic diagnosis
- Family planning
Research Status
Prophylactic thyroidectomy for MEN2 by age 5. Surveillance for MEN1 tumors. Surgical removal of tumors. Genetic testing for family members. Screening and early intervention improve outcomes.
Affected Countries
Sources
- https://www.ncbi.nlm.nih.gov/books/NBK1116
- https://medlineplus.gov/genetics
- https://rarediseases.org
Medical Disclaimer
This information is for educational purposes only. Always consult healthcare professionals for medical advice, diagnosis, and treatment.